Synonyms: compound 20 [PMID: 31589043]
Compound class:
Synthetic organic
Comment: AM-6494 is a beta-secretase 1 (BACE1) inhibitor that has been demonstrated oral efficacy in reducing central Aβ40 load in in vivo models [1]. It has been advanced to preclinical evaluation.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
AM-6494 reduces CSF and brain levels of Aβ40 in rat and monkey pharmacodynamic models [1]. It is devoid of inhibitory activity against cathepsin D. AM-6494 did not cause skin/fur hypopigmentation in a mouse model, which is indicative of its BACE2-sparing activity profile. |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|